Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2016-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1871520616666160422105920PMID 27102277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

  2016cited by this paper
• Melatonin decreases breast cancer metastasis by modulating Rho‐associated kinase protein‐1 expression

  2016cited by this paper
• The potential of CXCL5 as a target for liver cancer – what do we know so far?

  2015cited by this paper
• Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.

  2015cited by this paper
• Focal Adhesion Kinase Knockdown in Carcinoma‐Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis via Downregulating MCP‐1/CCL2 Expression

  2015cited by this paper
• Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice

  2015cited by this paper
• DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling

  2015cited by this paper
• Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.

  2014cited by this paper
• Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer

  2014cited by this paper
• Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

  2014cited by this paper
• Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: Potential as a serum biomarker

  2014cited by this paper
• CyTOF supports efficient detection of immune cell subsets from small samples.

  2014cited by this paper
• Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.

  2014cited by this paper
• Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

  2014cited by this paper
• Simultaneous Expression of Cancer Stem Cell-Like Properties and Cancer-Associated Fibroblast-Like Properties in a Primary Culture of Breast Cancer Cells

  2014cited by this paper
• Interleukin‐3‐mediated regulation of β‐catenin in myeloid transformation and acute myeloid leukemia

  2014cited by this paper
• Tumor stroma as targets for cancer therapy.

  2013cited by this paper
• Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer

  2013cited by this paper
• Melatonin Anticancer Effects: Review

  2013cited by this paper
• Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.

  2013cited by this paper
• Melatonin: Buffering the Immune System

  2013cited by this paper
• Melatonin inhibits matrix metalloproteinase‐9 activity by binding to its active site

  2013cited by this paper
• Cadherin-23 Mediates Heterotypic Cell-Cell Adhesion between Breast Cancer Epithelial Cells and Fibroblasts

  2012cited by this paper
• Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production

  2012cited by this paper
• Gene regulation by melatonin linked to epigenetic phenomena.

  2012cited by this paper
• Identification of CXCL5/ENA‐78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer‐associated fibroblasts

  2012cited by this paper
• Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

  2012cited by this paper
• Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.

  2012cited by this paper
• Thymus and activation‐regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration

  2011cited by this paper
• Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus

  2011cited by this paper
• Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-positive Breast Cancer Cells

  2011cited by this paper
• PI3K/AKT/mTOR Pathway in Angiogenesis

  2011cited by this paper
• IL-3 is a novel target to interfere with tumor vasculature

  2011cited by this paper
• Molecular Imaging of Changes in the Prevalence of Vascular Endothelial Growth Factor Receptor in Sunitinib-Treated Murine Mammary Tumors

  2010cited by this paper
• A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma

  2010cited by this paper
• Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts

  2009cited by this paper
• Tumor-host interactions: the role of inflammation

  2008cited by this paper
• The inflammatory chemokines CCL2 and CCL5 in breast cancer.

  2008cited by this paper
• Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis.

  2008cited by this paper
• Cytokine Comparisons Between Women With Breast Cancer and Women With a Negative Breast Biopsy

  2008cited by this paper
• MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.

  2002cited by this paper
• Melatonin activates Th1 lymphocytes by increasing IL-12 production.

  1999cited by this paper
• The paracrine role of tumour‐derived mIL‐4 on tumour‐associated endothelium

  1997cited by this paper

• Melatonin and Breast Cancer: A Review Article

  2025cites this paper
• Melatonin: A Potential Regulator of DNA Methylation

  2023cites this paper
• Antitumor effect of melatonin on breast cancer in experimental models: A systematic review.

  2022cites this paper
• Modulation of the tumor microenvironment (TME) by melatonin.

  2021cites this paper
• Melatonin indirectly decreases gastric cancer cell proliferation and invasion via effects on cancer-associated fibroblasts.

  2021cites this paper
• An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress

  2021cites this paper
• Therapeutic potential of melatonin in colorectal cancer: focus on lipid metabolism and gut microbiota.

  2021cites this paper
• Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved

  2021cites this paper
• Melatonin: An atypical hormone with major functions in the regulation of angiogenesis

  2020cites this paper
• Primer for Mainstreaming Mind-Body Techniques for Extreme Climates-Insights and Future Directions

  2020cites this paper
• The role of melatonin on miRNAs modulation in triple-negative breast cancer cells

  2020cites this paper
• Melatonin: An important anticancer agent in colorectal cancer

  2020cites this paper
• Melatonin and urological cancers: a new therapeutic approach

  2020cites this paper
• Boosting immune system against cancer by melatonin: A mechanistic viewpoint.

  2019cites this paper
• Pan‐cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types

  2019cites this paper
• RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model

  2019cites this paper
• Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.

  2019cites this paper
• Melatonin down-regulates microRNA-10a and decreases invasion and migration of triple-negative breast cancer cells

  2019cites this paper
• Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin

  2018cites this paper
• Melatonin May Increase Anticancer Potential of Pleiotropic Drugs

  2018cites this paper
• Mechanisms Underlying Tumor Suppressive Properties of Melatonin

  2018cites this paper
• Melatonin restrains angiogenic factors in triple‐negative breast cancer by targeting miR‐152‐3p: In vivo and in vitro studies

  2018cites this paper
• Efficacy of melatonin, IL‐25 and siIL‐17B in tumorigenesis‐associated properties of breast cancer cell lines

  2017cites this paper
• Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

  2017cites this paper
• Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis

  2017cites this paper